Kiromic BioPharma announces 1-for-30 reverse stock split

Kiromic BioPharma announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 effective as of 4:01 p.m. Eastern Time today, March 10. Kiromic common stock will begin trading on a split-adjusted basis when the market opens on March 13 under the existing trading symbol "KRBP." As a result of the reverse stock split, the CUSIP number for the company’s common stock will now be 497634204. The reverse stock split was previously approved by Kiromic stockholders at the Special Meeting of Stockholders held on March 7, with the final ratio determined by the company’s Board of Directors.